A Kappa Opioid Receptor Agonist Blocks Bone Cancer Pain Without Altering Bone Loss, Tumor Size, or Cancer Cell Proliferation in a Mouse Model of Cancer-Induced Bone Pain

Journal of Pain - United States
doi 10.1016/j.jpain.2018.01.002
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Morphine Treatment Accelerates Sarcoma-Induced Bone Pain, Bone Loss, and Spontaneous Fracture in a Murine Model of Bone Cancer

Pain
NeurologyAnesthesiologyPain MedicinePharmacology
2007English

Clinical and Genetic Factors Related to Cancer-Induced Bone Pain and Bone Pain Relief

Oncologist
Cancer ResearchMedicineOncology
2014English

A Model of Metastatic Bone Cancer Pain in the Lumbar Spine

Global Spine Journal
OrthopedicsSurgeryNeurologySports Medicine
2015English

Effect of the Norepinephrine Transporter (NET) Inhibition on Μ-Opioid Receptor (MOR)-Induced Anti-Nociception in a Bone Cancer Pain Model

Journal of Pharmacological Sciences
Molecular MedicinePharmacology
2014English

Grid-Climbing Behaviour as a Pain Measure for Cancer-Induced Bone Pain and Neuropathic Pain

In Vivo
BiochemistryMedicineGeneticsPharmacologyMolecular Biology
2017English

Blocking Mammalian Target of Rapamycin Alleviates Bone Cancer Pain and Morphine Toleranceviaµ-Opioid Receptor

International Journal of Cancer
Cancer ResearchOncology
2015English

Dual PI3 K/mTOR Inhibition Reduces Prostate Cancer Bone Engraftment Altering Tumor-Induced Bone Remodeling

Tumor Biology
MedicineCancer Research
2018English

Corrigendum to “Yokukansan Alleviates Cancer Pain by Suppressing Matrix Metalloproteinase-9 in a Mouse Bone Metastasis Model”

Evidence-based Complementary and Alternative Medicine
Alternative MedicineComplementary
2019English

Intrathecal Injection of Metabotropic Glutamate Receptor Subtype 3 and 5 Agonist/Antagonist Attenuates Bone Cancer Pain by Inhibition of Spinal Astrocyte Activation in a Mouse Model

Anesthesiology
AnesthesiologyPain Medicine
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy